‘ΑWkΰΖu‘ΓΜV½Θͺ¬l
xΰΙΞ·ιΖuCheck PointjQάΜLψ«
΄Ζ@³
ϊ{γΘεwεw@γw€ΘΔzνΰΘwͺμ
Efficacy of Immune Checkpoint Inhibitors in Lung Cancer
Masahiro Seike
Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School
ϊγεγο 2017; 13(3), 145-149
Key words
Lung cancer, Immune check point inhibitor
Correspondence to
Masahiro Seike, Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan
E-mailFmseike@nms.ac.jp
σtF2016N83ϊ@σF2017N529ϊ |
SΆPDF